News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Triple therapy controls hypertension, dyslipidaemia
30 Apr 2026
byElaine Soliven
Triple therapy with angiotensin receptor blockers (ARBs)/amlodipine + rosuvastatin significantly reduces blood pressure (BP) and cholesterol levels in patients with hypertension and dyslipidaemia compared with dual therapies involving ARBs/amlodipine or ARBs + rosuvastatin, according to a recent study.
Triple therapy controls hypertension, dyslipidaemia
30 Apr 2026
Improved oral care cuts pneumonia risk
29 Apr 2026
byAudrey Abella
Part 2 of the HAPPEN* trial shows a 60-percent reduction in the incidence of non-ventilator–associated hospital-acquired pneumonia (NV-HAP) among hospitalized patients with improved oral hygiene.







